戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  avenue for treating advanced intervertebral disc disease.
2 D3 may serve a critical role in degenerative disc disease.
3 toration of cell numbers during degenerative disc disease.
4 ADAMTS-5 protein expression with severity of disc disease.
5 loping biological therapies for degenerative disc disease.
6 ge of a new form of therapy for degenerative disc disease.
7 effective treatment of cervical degenerative disc disease.
8 es such as osteoarthritis and intervertebral disc disease.
9 that may be important in the pathogenesis of disc disease.
10 ed expression of NOTCH genes in degenerative disc disease.
11         To correlate these observations with disc disease, a condition characterized by tissue vascul
12 e studies show an association between lumbar disc disease and mutations of genes encoding the alpha-2
13 er inflammatory conditions that characterize disc disease are not yet known.
14 s a key role in pathogenesis of degenerative disc disease by promoting aggrecan degradation by ADAMTS
15                  Treatments for degenerative disc diseases continue to be a challenge.
16 enetic mutations in disorders such as lumbar disc disease, further investigation of the interaction b
17 udy 10-year follow-up who did not have optic disc disease, including glaucoma, were included.
18   Low back pain associated with degenerative disc disease is optimally treated with distraction of th
19 reed (PBonferroni = 0.01) and intervertebral disc disease (IVDD) across breeds (PBonferroni = 4.0 x 1
20 a positive association between SN and lumbar disc disease (LDD).
21 ing IL-1beta and TNF-alpha activities during disc disease may restore NOTCH signaling and nucleus pul
22 g this transcription factor for treatment of disc disease must spare osmoprotective, prosurvival, and
23 ere procured from patients with degenerative disc disease (n = 25) or herniated IVDs (n = 12); nondeg
24                                 Degenerative disc disease often causes severe low-back pain, a public
25  of the Th17 lymphocyte lineage in mediating disc disease remains uninvestigated.
26 lternative for the treatment of degenerative disc disease that is more logistically convenient than t
27                  The prevalence of diagnosed disc disease was 2.7 times greater in those with radiolo
28 provide potential therapies for degenerative disc disease, which is the major cause of lower back pai